Preference for enzalutamide capsules versus tablet pills in patients with prostate cancer.

In June 2018, the form of ENZ was changed from a 40-mg capsule (21 × 10 mm in size) to a 40-mg tablet pill (10.1 mm in diameter) or an 80-mg tablet pill (17.2 × 9.1 mm) in Japan and Germany. For the 25 CRPC patients, the mean number of drugs administered was six, with a total of 11 capsules and/or tablet pills. [Extracted from the article]